Latest 20-F annual reports

TROOPS, Inc. reports its 20-F filing for the fiscal year ended December 31, 2024, showcasing revenue growth and strategic business activities in money lending, property investment, and fintech services.

Abits Group Inc.'s 20-F filing reveals a significant revenue increase driven by bitcoin mining, but also highlights ongoing risks and operational adjustments.

Grupo Televisa's 2024 annual report highlights strategic shifts, including the TelevisaUnivision transaction and a focus on core cable and Sky segments, amidst a complex economic landscape.

Ellomay Capital Ltd. files its annual report on Form 20-F, detailing surface rights agreements for its Italian solar subsidiaries and providing an overview of its financial performance and risk factors.

Quhuo Limited's 20-F filing for FY2024 outlines its financial results, corporate structure, and associated risks, highlighting a year of fluctuating performance and strategic shifts.

Silicon Motion's 2024 annual report reveals a 26% increase in revenue, driven by strong performance in SSD and eMMC/UFS controllers.

Nebius Group N.V. reports a 600% growth in its core AI infrastructure business for 2024 and outlines its strategic focus on becoming a leading AI infrastructure provider.

Mercurity Fintech Holding Inc. releases its annual report on Form 20-F, outlining financial results, strategic business adjustments, and risk factors for the fiscal year ended December 31, 2024.

Adlai Nortye Ltd. reported continued net losses and substantial doubt about its ability to continue as a going concern in its 2024 annual report.

XTL Biopharmaceuticals diversifies its business by acquiring The Social Proxy, an AI web data company, while reporting a net loss for the fiscal year ended December 31, 2024.

Tower Semiconductor's 20-F filing outlines the company's compensation policies, business risks, and financial performance, highlighting its focus on specialty foundry services and global operations.

Intchains Group Limited files an amendment to its 20-F annual report to correct the date on the independent auditor's report.

Canagold Resources Ltd. files its annual report on Form 20-F, highlighting ongoing development at the New Polaris project and detailing financial results for the year ended December 31, 2024.

Akanda Corp. reports a reduced net loss for 2024, exits European operations, and advances plans for a Canadian cultivation facility and a merger with First Towers & Fiber Corp.

Oriental Rise Holdings Limited's 20-F filing details its financial results for the year ended December 31, 2024, along with its corporate structure and risk factors.

Inter&Co's 20-F filing highlights strategic moves in global expansion, regulatory compliance, and financial performance for the fiscal year 2024.

TNL Mediagene's 20-F filing provides a summary of the company's registered securities, including ordinary shares and warrants, and outlines key aspects of its corporate governance and shareholder rights under Cayman Islands law.

PS International Group Ltd. reports a decrease in revenue and a net loss for 2024, impacted by global trade tensions and internal control weaknesses.

Sequans Communications achieved a net profit in 2024, primarily due to a significant gain from the sale of its 4G IoT technologies to Qualcomm, while facing ongoing operational and financial challenges.

ChineseWorldNet.Com Inc. reported a net loss of $66,158 for the year ended December 31, 2024, and is still seeking opportunities to acquire or invest in other businesses.

Davis Commodities Limited's 20-F filing reveals a decrease in revenue for FY 2024, alongside a net loss, reflecting a challenging year for the agricultural commodity trading company.

Genoil Inc.'s Form 20-F filing reveals continued operating losses and reliance on external financing to sustain operations.

Natuzzi S.p.A.'s 20-F filing details the company's strategic focus on brand strengthening, retail expansion, and operational efficiency amidst challenging global economic conditions.

PureTech Health PLC announces its 2024 financial results, showcasing key achievements in therapeutic development and strategic initiatives.

Altamira Therapeutics shifts focus to RNA delivery technology, divesting legacy assets and reporting its financial results for the year ended December 31, 2024.

Qutoutiao Inc.'s 20-F filing for FY24 highlights efforts to manage financial challenges and maintain operations amidst economic uncertainties.

Allego N.V. reports a net loss but shows revenue growth, while addressing financial uncertainties and strategic shifts.

Luda Technology Group Limited's FY2024 results reveal a revenue decrease alongside ongoing efforts to comply with evolving regulatory requirements in China and Hong Kong.

NXT Energy Solutions Inc. reports its 2024 financial results, showcasing strategic progress in Africa and Southeast Asia, while addressing ongoing concerns about its ability to continue as a going concern.

Innate Pharma files its annual report on Form 20-F, detailing its financial performance and business activities for the fiscal year ended December 31, 2024.